首页 > 最新文献

Die Ophthalmologie最新文献

英文 中文
[Sepsis-induced superior ophthalmic vein thrombosis]. 脓毒症引起的眼上静脉血栓形成。
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2025-10-06 DOI: 10.1007/s00347-025-02323-6
Julian Bucur, Petra Dávidová, Silvia Schaffner, Tyll Jandewerth, Alessia Goth, Thomas Kohnen
{"title":"[Sepsis-induced superior ophthalmic vein thrombosis].","authors":"Julian Bucur, Petra Dávidová, Silvia Schaffner, Tyll Jandewerth, Alessia Goth, Thomas Kohnen","doi":"10.1007/s00347-025-02323-6","DOIUrl":"10.1007/s00347-025-02323-6","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"140-143"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145234444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Corneal allogeneic intrastromal ring segments]. [角膜异体真皮内环节段]。
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2025-12-11 DOI: 10.1007/s00347-025-02355-y
Hyeck-Soo Son, Laura Hüfner, Gerd U Auffarth, Maximilian Friedrich, Victor A Augustin

Background: Corneal allogeneic intrastromal ring segments (CAIRS) are a novel minimally invasive treatment option for keratoconus. Compared to synthetic intracorneal ring segments (ICRS), they offer greater biocompatibility and customizability thanks to the use of allogeneic tissue. The aim is to regularize the curvature of the cornea and improve visual acuity with as few complications as possible.

Objective: The aim of this review is to summarize and classify the current status of the efficacy, safety, patient selection, graft procurement and nomogram development in CAIRS.

Material and methods: A narrative literature review of relevant original studies, meta-analyses and review articles on CAIRS was conducted, supplemented by current clinical and technical developments as well as published nomograms (e.g., Jacob, Istanbul, Awwad, Brisbane).

Results: The literature shows consistent improvements in uncorrected and corrected distance visual acuity, Kmax and spherical equivalent. The CAIRS is associated with a low complication rate. Particularly positive results were achieved with individually customized segment geometry.

Conclusion: The CAIRS offers a high degree of customization and safety while maintaining good visual efficacy. Targeted patient selection is crucial for a good outcome. In the future, artificial intelligence (AI)-based nomograms could help to further optimize planning and improve the predictability of results.

背景:角膜异体间质环段(cair)是圆锥角膜的一种新型微创治疗方法。与合成角膜内环段(ICRS)相比,由于使用同种异体组织,它们具有更好的生物相容性和可定制性。其目的是使角膜曲率正常化,并在尽可能少的并发症的情况下改善视力。目的:本综述的目的是总结和分类cair的疗效、安全性、患者选择、移植物获取和nomogram发展的现状。材料和方法:对cair相关的原始研究、meta分析和综述文章进行了叙述性文献综述,并辅以当前的临床和技术发展以及已发表的nomograms(例如Jacob, Istanbul, Awwad, Brisbane)。结果:文献显示在未矫正和矫正的距离视力、Kmax和球面等效方面有一致的改善。cair的并发症发生率较低。特别积极的结果取得了单独定制的部分几何形状。结论:CAIRS在保持良好的视觉效果的同时,具有高度的定制性和安全性。有针对性的患者选择对良好的结果至关重要。未来,基于人工智能(AI)的诺图可以帮助进一步优化规划并提高结果的可预测性。
{"title":"[Corneal allogeneic intrastromal ring segments].","authors":"Hyeck-Soo Son, Laura Hüfner, Gerd U Auffarth, Maximilian Friedrich, Victor A Augustin","doi":"10.1007/s00347-025-02355-y","DOIUrl":"10.1007/s00347-025-02355-y","url":null,"abstract":"<p><strong>Background: </strong>Corneal allogeneic intrastromal ring segments (CAIRS) are a novel minimally invasive treatment option for keratoconus. Compared to synthetic intracorneal ring segments (ICRS), they offer greater biocompatibility and customizability thanks to the use of allogeneic tissue. The aim is to regularize the curvature of the cornea and improve visual acuity with as few complications as possible.</p><p><strong>Objective: </strong>The aim of this review is to summarize and classify the current status of the efficacy, safety, patient selection, graft procurement and nomogram development in CAIRS.</p><p><strong>Material and methods: </strong>A narrative literature review of relevant original studies, meta-analyses and review articles on CAIRS was conducted, supplemented by current clinical and technical developments as well as published nomograms (e.g., Jacob, Istanbul, Awwad, Brisbane).</p><p><strong>Results: </strong>The literature shows consistent improvements in uncorrected and corrected distance visual acuity, Kmax and spherical equivalent. The CAIRS is associated with a low complication rate. Particularly positive results were achieved with individually customized segment geometry.</p><p><strong>Conclusion: </strong>The CAIRS offers a high degree of customization and safety while maintaining good visual efficacy. Targeted patient selection is crucial for a good outcome. In the future, artificial intelligence (AI)-based nomograms could help to further optimize planning and improve the predictability of results.</p>","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"111-117"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145745892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum zu: Augeninnendruckentgleisung, Hyphäma und Uveitis bei chronischer lymphatischer Leukämie unter Ibrutinib-Therapie. Ibrutinib治疗慢性淋巴细胞白血病的眼压减退、血管炎和尿囊炎。
IF 0.6 Pub Date : 2026-02-01 DOI: 10.1007/s00347-025-02208-8
Abdelrahman Assaf, Fidan Aghayeva, Ines M Lanzl
{"title":"Erratum zu: Augeninnendruckentgleisung, Hyphäma und Uveitis bei chronischer lymphatischer Leukämie unter Ibrutinib-Therapie.","authors":"Abdelrahman Assaf, Fidan Aghayeva, Ines M Lanzl","doi":"10.1007/s00347-025-02208-8","DOIUrl":"10.1007/s00347-025-02208-8","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"65"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ophthalmological screening examinations in treatment with chloroquine or hydroxychloroquine : S1 guidelines of the German Society of Ophthalmology (DOG), the German Professional Association of Ophthalmologists (BVA) and the German Retina Society (RG)]. [氯喹或羟氯喹治疗的眼科筛查检查:德国眼科学会(DOG)、德国眼科专业协会(BVA)和德国视网膜学会(RG) S1指南]。
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2025-11-11 DOI: 10.1007/s00347-025-02337-0
{"title":"[Ophthalmological screening examinations in treatment with chloroquine or hydroxychloroquine : S1 guidelines of the German Society of Ophthalmology (DOG), the German Professional Association of Ophthalmologists (BVA) and the German Retina Society (RG)].","authors":"","doi":"10.1007/s00347-025-02337-0","DOIUrl":"10.1007/s00347-025-02337-0","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"50-63"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145490961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Publisher Erratum zu: Zentralvenenverschluss bei Marathon Runner’s Retinopathy. “马拉松运动员视网膜病变的中央静脉阻塞”。
IF 0.6 Pub Date : 2026-02-01 DOI: 10.1007/s00347-025-02331-6
Katja Steffen, Mareike Rockel, Burkhard von Jagow
{"title":"Publisher Erratum zu: Zentralvenenverschluss bei Marathon Runner’s Retinopathy.","authors":"Katja Steffen, Mareike Rockel, Burkhard von Jagow","doi":"10.1007/s00347-025-02331-6","DOIUrl":"10.1007/s00347-025-02331-6","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"64"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145152018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Testing contrast sensitivity in pilots over 60 years of age. Statement of the Transport Committee of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Status: 17 October 2025]. [测试60岁以上飞行员的对比敏感度。德国眼科学会(DOG)和德国眼科专业协会(BVA)运输委员会的声明。现状:2025年10月17日]。
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2025-12-04 DOI: 10.1007/s00347-025-02351-2
{"title":"[Testing contrast sensitivity in pilots over 60 years of age. Statement of the Transport Committee of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Status: 17 October 2025].","authors":"","doi":"10.1007/s00347-025-02351-2","DOIUrl":"10.1007/s00347-025-02351-2","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"118-120"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Congenital or early childhood acquired homonymous visual field defects and fitness to drive. Statement of the Transport Committee of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Status: 17 October 2025]. 先天性或幼儿期获得的同义视野缺陷和驾驶适应性。德国眼科学会(DOG)和德国眼科专业协会(BVA)运输委员会的声明。现状:2025年10月17日]。
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2025-12-04 DOI: 10.1007/s00347-025-02352-1
{"title":"[Congenital or early childhood acquired homonymous visual field defects and fitness to drive. Statement of the Transport Committee of the German Society of Ophthalmology (DOG) and the German Professional Association of Ophthalmologists (BVA). Status: 17 October 2025].","authors":"","doi":"10.1007/s00347-025-02352-1","DOIUrl":"10.1007/s00347-025-02352-1","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"121-122"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145679597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Recent advancements in corneal diagnostics and individualized tissue additive procedures for treatment of keratoconus]. [角膜诊断和治疗圆锥角膜的个性化组织添加程序的最新进展]。
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2026-02-03 DOI: 10.1007/s00347-025-02363-y
Gerd U Auffarth, Hyeck-Soo Son, Victor A Augustin
{"title":"[Recent advancements in corneal diagnostics and individualized tissue additive procedures for treatment of keratoconus].","authors":"Gerd U Auffarth, Hyeck-Soo Son, Victor A Augustin","doi":"10.1007/s00347-025-02363-y","DOIUrl":"https://doi.org/10.1007/s00347-025-02363-y","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":"123 2","pages":"93-94"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146115229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sulphur hexafluoride (SF6) and climate impact: is the medical use still justified?] 六氟化硫(SF6)与气候影响:医疗用途是否仍然合理?]
IF 0.6 Pub Date : 2026-02-01 Epub Date: 2025-11-28 DOI: 10.1007/s00347-025-02356-x
Tim U Krohne, Johannes Birtel, Peter Charbel Issa

Background: Sulphur hexafluoride (SF6) is commonly used in surgical treatment of retinal detachment and macular holes as well as in Descemet membrane endothelial keratoplasty (DMEK). At the same time, SF6 is by far the most climate-damaging greenhouse gas known, with a global warming potential 24,300 times higher than carbon dioxide (CO2).

Objective: Assessment of the climate impact of the ophthalmological surgical use of SF6.

Material and methods: Systematic literature search.

Results: The CO2 equivalent of the amount of SF6 consumed during a vitrectomy corresponds to driving 9 km by car with a combustion engine. Replacing SF6 with other endotamponades can be associated with medical disadvantages. For example, the likewise climate-damaging gases hexafluoroethane (C2F6) and octafluoropropane (C3F8) result in prolonged visual rehabilitation, silicone oil in the need for a second surgery, and air in a possibly poorer efficacy depending on the indications. The use of SF6 should be reduced as far as medically possible, e.g. by avoiding unused excess gas during surgery. Additional changes with significant climate-protective effect include reducing or recycling operation room waste, switching from anesthetic gas to intravenous or local anesthesia, and reducing follow-up visits.

Conclusion: Medical practices need to be reviewed regularly for their impact on climate change and adapted if necessary. This should, however, not result in medical disadvantages for the patient. Randomized clinical trials appear vital to assess whether greenhouse gases as tamponades can be replaced by air for specific forms of ophthalmological surgery.

背景:六氟化硫(SF6)常用于视网膜脱离和黄斑孔的手术治疗以及Descemet膜内皮角膜移植术(DMEK)。与此同时,SF6是迄今为止已知的最具气候破坏性的温室气体,其全球变暖潜力比二氧化碳(CO2)高24,300倍。目的:评价SF6在眼科手术中使用对气候的影响。材料与方法:系统文献检索。结果:在玻璃体切割过程中消耗的SF6量的二氧化碳当量对应于内燃机汽车行驶9 公里。用其他内填塞物代替SF6可能会带来医疗上的不利影响。例如,同样破坏气候的气体六氟乙烷(C2F6)和八氟丙烷(C3F8)导致视力恢复时间延长,硅油需要第二次手术,而空气的效果可能较差,具体取决于适应症。在医学上可能的情况下,应尽量减少SF6的使用,例如避免在手术期间使用多余的气体。具有显著气候保护作用的其他变化包括减少或回收手术室废物,从麻醉气体改为静脉或局部麻醉,以及减少随访。结论:需要定期审查医疗实践对气候变化的影响,并在必要时进行调整。然而,这不应该给病人带来医疗上的不利。随机临床试验对于评估在特定形式的眼科手术中是否可以用空气代替温室气体作为填塞物显得至关重要。
{"title":"[Sulphur hexafluoride (SF<sub>6</sub>) and climate impact: is the medical use still justified?]","authors":"Tim U Krohne, Johannes Birtel, Peter Charbel Issa","doi":"10.1007/s00347-025-02356-x","DOIUrl":"10.1007/s00347-025-02356-x","url":null,"abstract":"<p><strong>Background: </strong>Sulphur hexafluoride (SF<sub>6</sub>) is commonly used in surgical treatment of retinal detachment and macular holes as well as in Descemet membrane endothelial keratoplasty (DMEK). At the same time, SF<sub>6</sub> is by far the most climate-damaging greenhouse gas known, with a global warming potential 24,300 times higher than carbon dioxide (CO<sub>2</sub>).</p><p><strong>Objective: </strong>Assessment of the climate impact of the ophthalmological surgical use of SF<sub>6</sub>.</p><p><strong>Material and methods: </strong>Systematic literature search.</p><p><strong>Results: </strong>The CO<sub>2</sub> equivalent of the amount of SF<sub>6</sub> consumed during a vitrectomy corresponds to driving 9 km by car with a combustion engine. Replacing SF<sub>6</sub> with other endotamponades can be associated with medical disadvantages. For example, the likewise climate-damaging gases hexafluoroethane (C<sub>2</sub>F<sub>6</sub>) and octafluoropropane (C<sub>3</sub>F<sub>8</sub>) result in prolonged visual rehabilitation, silicone oil in the need for a second surgery, and air in a possibly poorer efficacy depending on the indications. The use of SF<sub>6</sub> should be reduced as far as medically possible, e.g. by avoiding unused excess gas during surgery. Additional changes with significant climate-protective effect include reducing or recycling operation room waste, switching from anesthetic gas to intravenous or local anesthesia, and reducing follow-up visits.</p><p><strong>Conclusion: </strong>Medical practices need to be reviewed regularly for their impact on climate change and adapted if necessary. This should, however, not result in medical disadvantages for the patient. Randomized clinical trials appear vital to assess whether greenhouse gases as tamponades can be replaced by air for specific forms of ophthalmological surgery.</p>","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"128-132"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145643591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum zu: Trabekuläre, suprachoroidale und subkonjunktivale innovative Glaukomchirurgie. “小叶,脉络膜上和结膜下创新青光眼手术”。
IF 0.6 Pub Date : 2026-02-01 DOI: 10.1007/s00347-025-02343-2
{"title":"Erratum zu: Trabekuläre, suprachoroidale und subkonjunktivale innovative Glaukomchirurgie.","authors":"","doi":"10.1007/s00347-025-02343-2","DOIUrl":"10.1007/s00347-025-02343-2","url":null,"abstract":"","PeriodicalId":72808,"journal":{"name":"Die Ophthalmologie","volume":" ","pages":"34"},"PeriodicalIF":0.6,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145574981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Die Ophthalmologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1